Morning Preview: $JCP Upgraded, Fuel Cell Mania, And Today’s Winner In Biotech

Once again both $PLUG and $BLDP are the top trending tickers on StockTwits. The two fuel cell companies have caught just about everyone’s attention over the last few weeks and yesterday in our market wrap @ChicagoSean wrote why this is both incredibly exciting, but also terrifying.

The simple fact is $PLUG has gone from 12 cents to 12 dollars in 12 months and yesterday $PLUG’s market cap climbed above $1 billion for the first time since 2000. Below we’ve shared two charts that highlight total message volume on the $PLUG and $BLDP streams. The huge increase in message volume on these two stocks says everything you need to know about everyone’s interest in them:

This is why you watch Sentiment and Message Volume stats on StockTwits. Look at $PLUG $BLDP:

— StockTwits Data (@StockTwitsData) Mar. 11 at 08:29 AM

What else is trending on StockTwits? J.C. Penney, $JCP was upgraded by Citigroup. They raised their price target on the stock to $11 from $7.50. A fantastic new StockTwits user named @EconDaily shared a blog post summarizing the upgrade:

$JCP Citi Upgrades JC Penney to Buy, raises Price Target to $11 (Updated)

— The Economic Daily (@Econdaily) Mar. 11 at 06:03 AM

Several great traders on StockTwits are watching National Bank of Greece, $NBG, today. In a blog post shared on the StockTwits $NBG stream yesterday, @UpsideTrader explained, “We saw the National Bank of Greece ($NBG) rip through its 50 and 200 day moving averages like a hot knife through a lamb chop”:

New Post: Chunky Monday $PLUG $NBG $IBB $REGN $HLF

— joe donohue (@upsidetrader) Mar. 10 at 05:30 PM

Biotech has been one of the hottest sectors of the year and it feels like each day there is a new company in the sector spiking 50% in less than a few hours. Today, that company appears to be La Jolla Pharmaceutical, $LJPC, which is up 60% in pre-market trading on positive test data for its kidney disease drug:

La Jolla Pharma ($LJPC) Price Target Raised at Wedbush Following Positive GCS-100 Trial

— SIAnalystWire (@AnalystWire) Mar. 11 at 08:17 AM

Tickers: , , , ,

blog comments powered by Disqus
StockTwits Blog
  • StockTwits® is the world's largest social network for investors and traders. Anyone can share ideas about their favorite stocks or follow what others are saying in real-time. The quickest way to get started is to join right now and make sure you sign-up for our FREE email list.

    We also have a FREE app on the iPhone and Android app stores. Get it today.

  • Search by Date

  • Join StockTwits